SB3801 - 104th General Assembly (2025-2026)

PRESCRIPTION LABELING
Last Action
3/25/2026 - Senate: Postponed - Executive
Statutes Amended In Order of Appearance
225 ILCS 60/33  from Ch. 111, par. 4400-33
225 ILCS 85/22  from Ch. 111, par. 4142
Synopsis As Introduced
Amends the Medical Practice Act of 1987. In provisions concerning legend drugs, provides that, at the request of a person dispensing a drug or medicine, the label affixed to a box, bottle, vessel, or package containing mifepristone, misoprostol, or any generic alternative may include the name of the dispensing health care practice instead of the name of the person dispensing the drug or medicine. Amends the Pharmacy Practice Act. In provisions concerning the label of a drug, medicine, or poison that is lawfully sold or dispensed, provides that, at a prescriber's request, the label affixed to a box, bottle, vessel, or package containing mifepristone, misoprostol, or any generic alternative may include the name of the prescribing health care practice instead of the name of the prescriber.
Actions
DateChamberAction
2/06/2026SenateFiled with Secretary by Sen. Celina Villanueva
2/06/2026SenateFirst Reading
2/06/2026SenateReferred to Assignments
2/11/2026SenateAdded as Co-Sponsor Sen. Rachel Ventura
2/24/2026SenateAssigned to Executive
2/25/2026SenateAdded as Co-Sponsor Sen. Suzy Glowiak Hilton
2/27/2026SenateAdded as Co-Sponsor Sen. Mark L. Walker
3/05/2026SenateAdded as Co-Sponsor Sen. Adriane Johnson
3/11/2026SenatePostponed - Executive
3/13/2026SenateRule 2-10 Committee Deadline Established As March 27, 2026
3/25/2026SenateAdded as Co-Sponsor Sen. Mattie Hunter
3/25/2026SenatePostponed - Executive
3/25/2026SenateAdded as Co-Sponsor Sen. Emil Jones, III
3/27/2026SenateRule 2-10 Committee Deadline Established As April 24, 2026
3/27/2026SenateAdded as Co-Sponsor Sen. Graciela Guzmán